LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

Начало・Списък с акции・Alcon Inc

Alcon Inc

Затворен

СекторЗдравеопазване

81.26 -1.56

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

79.47

Максимум

82.55

Ключови измерители
By Trading Economics
Приходи	-21M 217M
Продажби	104M 2.7B
P/E Средно за сектора	42.768 66.845
Дивидентна доходност	0.39
Марж на печалбата	7.984
Служители	25,942
EBITDA	-144M 521M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+15.63% upside

Дивиденти
By Dow Jones
Дивидентна доходност Средно за сектора	0.39% 2.25%
Следващи печалби	4.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	1.5B 42B
Предишно отваряне	82.82
Предишно затваряне	81.26

Настроения в новините

By Acuity

50%

154 / 351 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Bullish Evidence

95.77 / 97.61 Подкрепа & съпротива

Alcon Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

6.01.2026 г., 15:11 ч. UTC

Придобивния, сливания и поглъщания

Staar Surgical Shareholders Reject $1.6 Billion Acquisition by Alcon in Activist Win

9.12.2025 г., 18:51 ч. UTC

Придобивния, сливания и поглъщания

Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical

9.12.2025 г., 15:54 ч. UTC

Значими двигатели на пазара

Придобивния, сливания и поглъщания

Staar Surgical Shares Surge as Alcon Boosts its Buyout Price

9.12.2025 г., 14:32 ч. UTC

Придобивния, сливания и поглъщания

Alcon Upgrades Offer Price for Staar Surgical

12.11.2025 г., 09:09 ч. UTC

Печалби

Значими двигатели на пазара

Alcon Shares in Switzerland Climb After Guidance Confirmation

25.02.2026 г., 22:29 ч. UTC

Придобивния, сливания и поглъщания

Lensar Expects to Close Transaction in 1H of 2026 >LNSR

25.02.2026 г., 22:29 ч. UTC

Придобивния, сливания и поглъщания

Lensar, Alcon Continue to Cooperate With FTC in Connection With Request for Additional Info >LNSR

25.02.2026 г., 22:28 ч. UTC

Придобивния, сливания и поглъщания

LENSAR Provides Update on Pending Acquisition by Alcon

24.02.2026 г., 21:41 ч. UTC

Печалби

Alcon 4Q Rev $2.72B >ALC.EB

7.01.2026 г., 01:00 ч. UTC

Придобивния, сливания и поглъщания

Alcon Terminates Agreement To Acquire STAAR Surgical >ALC

6.01.2026 г., 22:03 ч. UTC

Придобивния, сливания и поглъщания

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6.01.2026 г., 22:03 ч. UTC

Придобивния, сливания и поглъщания

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6.01.2026 г., 15:21 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Staar May See Management Turnover After Alcon Bid Is Rejected -- Market Talk

6.01.2026 г., 14:56 ч. UTC

Придобивния, сливания и поглъщания

Staar Surgical Shareholders Reject $1.6B Acquisition by Alcon in Activist Win

6.01.2026 г., 14:14 ч. UTC

Придобивния, сливания и поглъщания

Staar Surgical: Will Remain a Standalone, Publicly Traded Co and Continue to Trade on Nasdaq >STAA

6.01.2026 г., 14:14 ч. UTC

Придобивния, сливания и поглъщания

Staar Surgical: No Termination Fee Will Be Payable by Either Party >STAA

6.01.2026 г., 14:14 ч. UTC

Придобивния, сливания и поглъщания

Staar Surgical: Intend to Terminate Merger Agreement With Alcon >STAA

6.01.2026 г., 14:13 ч. UTC

Придобивния, сливания и поглъщания

Staar Surgical: Did Not Receive Necessary Stockholder Votes to Approve Merger Agreement With Alcon >STAA

9.12.2025 г., 14:17 ч. UTC

Придобивния, сливания и поглъщания

Alcon Ups Offer Price for Staar Surgical

9.12.2025 г., 13:34 ч. UTC

Придобивния, сливания и поглъщания

Alcon: Transaction Now Represents a Total Equity Value of $1.6B >ALC.EB

9.12.2025 г., 13:33 ч. UTC

Придобивния, сливания и поглъщания

Alcon: Purchase Price Increase Represents an Additional $150M >ALC.EB

9.12.2025 г., 13:33 ч. UTC

Придобивния, сливания и поглъщания

Alcon: Under the Terms of the Amended Agreement, Alcon Will Purchase All Outstanding Shrs of STAAR for $30.75 Per Shr in Cash >ALC.EB

9.12.2025 г., 13:33 ч. UTC

Придобивния, сливания и поглъщания

Alcon To Finance Transaction Through Issuance of Short- and Long-Term Credit Facilities >ALC

9.12.2025 г., 13:32 ч. UTC

Придобивния, сливания и поглъщания

Alcon: "Go-shop" Window Expired on Dec 6 >ALC.EB

9.12.2025 г., 13:32 ч. UTC

Придобивния, сливания и поглъщания

Alcon: Transaction Now Represents Total Equity Value of About $1.6B >ALC

9.12.2025 г., 13:31 ч. UTC

Придобивния, сливания и поглъщания

Alcon Will Purchase All Outstanding Shrs of STAAR for $30.75 Per Shr in Cash >ALC

9.12.2025 г., 13:31 ч. UTC

Придобивния, сливания и поглъщания

Alcon Announces Amended Merger Agreement With STAAR Surgical

9.12.2025 г., 13:31 ч. UTC

Придобивния, сливания и поглъщания

Alcon Enters Amended Merger Agreement for Acquisition of STAAR Surgical >ALC

12.11.2025 г., 08:46 ч. UTC

Пазарно говорене

Alcon's Guidance Reiteration Offers Relief -- Market Talk

11.11.2025 г., 21:35 ч. UTC

Печалби

Alcon 3Q Adj EPS 79c >ALC

Сравнение с други в отрасъла

Ценова промяна

Alcon Inc Прогноза

Ценова цел

By TipRanks

15.63% нагоре

12-месечна прогноза

Среден 95.42 USD 15.63%

Висок 108.905 USD

Нисък 76.874 USD

Според 12 анализатори от Wall Street, предложили 12-месечна ценова цел за Alcon Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

12 ratings

Купи

Задържане

Продай

Според 12 анализатори, дали борсови рейтинги на Alcon Inc през последните 3 месеца.

Техническа оценка

By Trading Central

95.77 / 97.61Подкрепа & съпротива

Bullish events outweigh bearish events.

All events are bullish.

Настроение

By Acuity

154 / 351 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Alcon Inc

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.